FDA Seeks More Authority to Oversee CBD Products

FDA Seeks More Authority to Oversee CBD Products

The New York Times - Business:

The agency wants Congress to intervene, saying it does not have adequate oversight powers to ensure the safety of the myriad cannabidiol products derived from hemp.

Andrew Jacobs
Author: Andrew Jacobs

This post first appeared in The New York Times - Business. Read the original article.